2.5200
0.0000
(0.00%)
At close: 4:00:01 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BEETHAM PETER RONALD Chief Executive Officer | Conversion of Exercise of derivative security | Dec 31, 2024 | 382,437 |
| BROOS CARLO Chief Financial Officer | Sale | Nov 12, 2024 | 74,197 |
| FREY TRAVIS Chief Technology Officer | Stock Award(Grant) | May 31, 2023 | 19,060 |
| FRIMERMAN DEBRA H. General Counsel | Stock Award(Grant) | May 31, 2023 | 18,772 |
| GOCAL GREG FRANCIS WILLIAM Officer | Sale | Jul 15, 2024 | 314,844 |
| KING WADE HAMPTON M.D. Chief Financial Officer | Stock Award(Grant) | May 31, 2023 | 212,100 |
| KOSCHAK WILLIAM Chief Financial Officer | Stock Award(Grant) | May 31, 2023 | 19,506 |
| LEHMANN JEAN-PIERRE JULES Director | Stock Award(Grant) | May 30, 2024 | 77,857 |
| PRANTE GERHARD Director | Sale | Feb 3, 2025 | 26,107 |
| RIGGS RORY B Chief Executive Officer | Conversion of Exercise of derivative security | Dec 31, 2024 | 4,858,620 |
Related Tickers
ANEB Anebulo Pharmaceuticals, Inc.
1.5700
+3.29%
CLYM Climb Bio Inc
1.9000
+1.60%
ANL Adlai Nortye Ltd.
2.0800
-2.80%
FULC Fulcrum Therapeutics, Inc.
3.9100
+2.36%
EDSA Edesa Biotech, Inc.
1.9500
+0.52%
ABP Abpro Holdings, Inc.
0.9900
+3.13%
LIPO Lipella Pharmaceuticals Inc.
2.5800
+1.18%
ENTA Enanta Pharmaceuticals, Inc.
5.07
-0.98%
BOLD Boundless Bio, Inc.
2.5000
+14.16%
CASI CASI Pharmaceuticals, Inc.
2.5500
-1.16%